-+ 0.00%
-+ 0.00%
-+ 0.00%

REVIVA PHARMACEUTICALS HOLDINGS - TO INITIATE TRIAL ACTIVITIES IN Q2 2026 , BEGIN ENROLLMENT IN Q3 2026, FOR RECOVER-2 - SEC FILING

Reuters·04/15/2026 12:06:43

Please log in to view news